Cargando…
Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
The objective of our study is to assess change in QTc interval with Regadenoson administration during myocardial perfusion imaging (MPI). We conducted a retrospective, observational analysis of 1497 consecutive patients who underwent pharmacological radionuclide MPI. On multivariate logistic regress...
Autores principales: | Rafiq, Arsalan, Chughtai, Tausif, Ashraf, Umair, Patel, Yash, Raiszadeh, Farbod, Sklyar, Eduard, Afshar, Maryam, Bella, Jonathan N., Kamalakkannan, Gayathri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474107/ https://www.ncbi.nlm.nih.gov/pubmed/32861387 http://dx.doi.org/10.1016/j.ihj.2020.06.015 |
Ejemplares similares
-
Cardiac Evaluation and Monitoring of Patients Undergoing Noncardiac Surgery
por: Rafiq, Arsalan, et al.
Publicado: (2017) -
Issues in QT interval measurement
por: Lanjewar, Pallavi, et al.
Publicado: (2004) -
Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015) -
Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019) -
Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)